Tolerance Induction Strategies in Organ Transplantation: Current Status and Future Perspectives

Area of Science:

• Immunology
• Transplantation Science
• Cell Therapy

Background:

• Donor-specific immune tolerance can eliminate lifelong immunosuppression in transplant recipients.
• Human memory T cells pose a significant barrier to tolerance induction, unlike in laboratory rodents.
• Current methods like hematopoietic chimerism and non-myeloablative conditioning have limitations including toxicity and graft-versus-host disease (GVHD).

Purpose of the Study:

• To review current challenges and emerging strategies for achieving donor-specific immune tolerance in transplantation.
• To explore alternative approaches that mitigate risks associated with traditional tolerance induction methods.
• To highlight recent innovations that may improve the precision, durability, and safety of transplantation tolerance.

Main Methods:

• Review of existing literature on immune tolerance induction in transplantation.
• Analysis of strategies including hematopoietic chimerism, thymus transplantation, and regulatory cell therapies.
• Discussion of novel approaches such as IL-2 pathway modulation and CAR-redirected regulatory T cells.

Main Results:

• Full donor hematopoietic chimerism can induce tolerance but carries risks like GVHD.
• Mixed and transient chimerism offer a less toxic alternative but face durability and resistance issues.
• Thymus transplantation and regulatory cell therapies show promise, with early clinical trials yielding encouraging results.

Conclusions:

• Overcoming memory T cell resistance is crucial for successful immune tolerance.
• Regulatory cell therapies and thymus transplantation represent safer and potentially more effective strategies.
• Innovations in IL-2 modulation and genetic engineering offer future avenues for enhancing transplantation tolerance.